市場調查報告書
商品編碼
950831

子宮頸癌症篩檢的全球市場:市場規模、患者數、死亡人數的預測,各檢驗手法 (子宮頸抹片(PAP),HPV DNA,VIA)、各國 (19個國家)

Cervical Cancer Screening Market, Patients, Mortality Global Forecast by Tests Type (Pap Smear, HPV DNA, VIA), 19 Countries Analysis

出版日期: | 出版商: Renub Research | 英文 292 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球子宮頸癌是女性最常見的癌症。2019年,在全球估計有2億8315萬個女性診斷出子宮頸癌,2018年約有31萬1000名女性因此死亡。子宮頸癌診察的市場規模,預計至2026年達165億美元。但,由於新型冠狀病毒感染疾病 (COVID-19)的影響目前也認為市場成長率將降低。

本報告提供全球子宮頸癌症診察 (篩檢) 市場相關分析,全球及各地區、各國 (共19個國家)的檢驗人口、市場收益額趨勢預測,及檢驗手法詳細趨勢,子宮頸癌症死亡人數的變化,主要的推動及阻礙市場要素等資訊,為您概述為以下內容。

目錄:

第1章 簡介

第2章 分析方法

第3章 摘要整理

第4章 全球子宮頸癌症診察 (篩檢) 人口

  • 亞洲
  • 歐洲
  • 北美
  • 其他地區

第5章 全球子宮頸癌症診察 (篩檢) 市場

  • 子宮頸抹片(PAP)檢驗 (篩檢)
  • HPV DNA檢驗 (篩檢)

第6章 全球子宮頸癌症診察 (篩檢) 市場:各地區

  • 亞洲
  • 歐洲
  • 北美
  • 其他國家 (RoW)

第7章 全球子宮頸癌症診察 (篩檢) 市場:人口占有率

  • 各地區
  • 各國

第8章 全球子宮頸癌症診察 (篩檢) 市場:市場佔有率結構

  • 各地區:子宮頸癌症診察 (篩檢)
  • 各國:子宮頸癌症診察 (篩檢)
  • 各國:子宮頸抹片(PAP)檢驗 (篩檢)
  • 各國:HPV DNA檢驗 (篩檢)
  • 各國:VIA檢驗 (篩檢)

第9章 英國的子宮頸癌症診察市場分析

  • 英國的子宮頸癌症診察 (篩檢) 人口與其預測
    • 子宮頸抹片(PAP)檢驗人口
    • HPV DNA檢驗族群
  • 英國的子宮頸癌症死亡人數
  • 英國的子宮頸癌症診察 (篩檢) 市場規模與其預測
    • 子宮頸抹片(PAP)檢驗市場
    • HPV DNA檢驗市場

第10章 法國的子宮頸癌症診察市場分析

第11章 德國的子宮頸癌症診察市場分析

第12章 義大利的子宮頸癌症診察市場分析

第13章 西班牙的子宮頸癌症診察市場分析

第14章 瑞典的子宮頸癌症診察市場分析

第15章 瑞士的子宮頸癌症診察市場分析

第16章 挪威的子宮頸癌症診察市場分析

第17章 荷蘭的子宮頸癌症診察市場分析

第18章 美國的子宮頸癌症診察市場分析

第19章 加拿大的子宮頸癌症診察市場分析

第20章 日本的子宮頸癌症診察市場分析

第21章 韓國的子宮頸癌症診察市場分析

第22章 新加坡的子宮頸癌症診察市場分析

第23章 馬來西亞的子宮頸癌症診察市場分析

第24章 印度的子宮頸癌症診察市場分析

第25章 中國的子宮頸癌症診察市場分析

第26章 泰國的子宮頸癌症診察市場分析

第27章 印尼的子宮頸癌症診察市場分析

第28章 其他的國家 (RoW)的子宮頸癌症診察市場分析

第29章 成長促進因素

  • 低成本VIA檢驗的引進
    • 國家計劃提供VIA測試的國家
    • 測試計劃提供VIA測試的國家
  • HPV感染患者的高得病率
  • 英國的子宮頸癌症的發生率的增加
  • 10代的妊娠全球的增加率

第30章 課題

  • 缺乏恰當的醫療基礎設施
  • 全球人類乳突病毒(HPV)疫苗接種計劃的引進
目錄

Globally, cervical cancer is the most appearing cancer in women. Cervical cancer is most frequently diagnosed in women between the age of 35 and 44 with the average age of diagnosis being 50. In 2019, an estimated 283.15 Million women were diagnosed with cervical cancer worldwide, and about 311,000 women died from the disease in 2018. Cervical cancer is the fourth most common cancer prevailing in women and the seventh in terms of overall cancer incidences. There are three types of screening for identifying cervical cancer they are Pap Smear Tests, Human Papillomavirus Virus (HPV) Tests and Visual Inspection with Acetic Acid (VIA) Tests. These screenings are key factor anticipated to boost the number of screening tests over the forecast period. Effective primary (HPV vaccination) approach (testing and treating precancerous lesions) will prevent most cervical cancer cases. According to Renub Research report, Cervical Cancer Screening Market is expected to be USD 16.5 Billion by 2026.

This report provides 19 Countries cervical cancer market analysis & forecast with numbers of screening & Mortality. In the United States, the medical community has made great strides in preventing and controlling cervical cancer. The reasons that influence world market dominance are the presence of technological advancements in terms of new diagnostic equipment, diagnostic procedures, favorable government policies related to reimbursement and screening techniques are expected to have a positive impact on the market. Cervical cancer is one of the leading causes of female cancer deaths in low- and middle-income countries.

COVID-19 impacts Global Cervical Cancer Screening Industry

The cervical cancer screening declined to meager numbers due to pandemic coronavirus. Mostly non-urgent cervical cancer appointments have been cancelled in the wake of COVID-19. However, things started moving in the last two quarters, but it will not return to pre-COVID numbers this year. As preventive measures should put in place during the efforts of providing cervical cancer screening as directed by the health authorities. Read the complete analysis on how COVID-19 has affected the cervical cancer screening market and its future?

According to Renub Research report "Cervical Cancer Market, Patients, Mortality Global Forecast by Tests (Pap Smear, HPV DNA, VIA), 19 Countries (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands, United States, Canada, Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia)"

Cervical Cancer Screening Market & Population - the report studies all 3 types of Test

  • Pap Smear Tests Market
  • HPV DNA Tests Market
  • VIA Tests Market

Cervical Cancer Mortality Population

In this section number of deaths by cervical cancer in all the 19 countries from 2014 to 2020 has been captured. The report gives complete insights of Market, Screened Population & Mortality of 19 countries, which provides a general idea of worldwide countries analysis of Global Cervical Cancer Screening Industry.

1. United Kingdom

2. France

3. Germany

4. Italy

5. Spain

6. Sweden

7. Switzerland

8. Norway

9. Netherlands

10. United States

11. Canada

12. Japan

13. Korea

14. Singapore

15. Malaysia

16. India

17. China

18. Thailand

19. Indonesia

Table of Contents:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Cervical Cancer Test (Screening) Population

  • 4.1 Asia
  • 4.2 Europe
  • 4.3 North America
  • 4.4 Rest of World

5. Global Cervical Cancer Test (Screening) Market

  • 5.1 Pap Smear Test (Screening)
  • 5.2 HPV DNA Test (Screening)

6. By Region - Global Cervical Cancer Test (Screening) Market Analysis

  • 6.1 Asia
  • 6.2 Europe
  • 6.3 North America
  • 6.4 Rest of World

7. Population Share - Global Cervical Cancer Test (Screening)

  • 7.1 By Region
  • 7.2 By Countries

8. Market Share - Global Cervical Cancer Test (Screening)

  • 8.1 Region - Cervical Cancer Test (Screening)
  • 8.2 Countries - Cervical Cancer Test (Screening)
  • 8.3 Countries - Pap Smear Test (Screening)
  • 8.4 Countries - HPV DNA Test (Screening)
  • 8.5 Countries - VIA Test (Screening)

9. United Kingdom - Cervical Cancer Test Analysis

  • 9.1 United Kingdom Cervical Cancer Test (Screening) Population & Forecast
    • 9.1.1 United Kingdom Pap Smear Test Population
    • 9.1.2 United Kingdom HPV DNA Test Population
  • 9.2 United Kingdom Cervical Cancer Deaths
  • 9.3 United kingdom Cervical Cancer Test (Screening) Market & Forecast
    • 9.3.1 United Kingdom Pap Smear Test Market
    • 9.3.2 United Kingdom HPV DNA Test Market

10. France - Cervical Cancer Test Analysis

  • 10.1 France Cervical Cancer Test (Screening) Population & Forecast
    • 10.1.1 France Pap Smear Test Population
    • 10.1.2 France HPV DNA Test Population
  • 10.2 France Cervical Cancer Mortality
  • 10.3 France Cervical Cancer Test (Screening) Market & Forecast
    • 10.3.1 France Pap Smear Test Market
    • 10.3.2 France HPV DNA Test Market

11. Germany - Cervical Cancer Test Analysis

  • 11.1 Germany Cervical Cancer Test (Screening) Population & Forecast
    • 11.1.1 Germany Pap Smear Test Population
    • 11.1.2 Germany HPV DNA Test Population
  • 11.2 Germany Cervical Cancer Mortality
  • 11.3 Market - Cervical Cancer Test (Screening)
    • 11.3.1 Germany Pap Smear Test Market
    • 11.3.2 Germany HPV DNA Test Market

12. Italy - Cervical Cancer Test Analysis

  • 12.1 Cervical Cancer Test (Screening) Population & Forecast
    • 12.1.1 Italy Pap Smear Test Population
    • 12.1.2 Italy HPV DNA Test Population
  • 12.2 Italy Cervical Cancer Mortality
  • 12.3 Italy Cervical Cancer Test (Screening) Market & Forecast
    • 12.3.1 Italy Pap Smear Test Market
    • 12.3.2 Italy HPV DNA Test Market

13. Spain - Cervical Cancer Test Analysis

  • 13.1 Spain Cervical Cancer Test (Screening) Population & Forecast
    • 13.1.1 Spain Pap Smear Test Population
    • 13.1.2 Spain HPV DNA Test Population
  • 13.2 Spain Cervical Cancer Mortality
  • 13.3 Spain Cervical Cancer Test (Screening) Market & Forecast
    • 13.3.1 Spain Pap Smear Test Market
    • 13.3.2 Spain HPV DNA Test Market

14. Sweden - Cervical Cancer Test Analysis

  • 14.1 Sweden Cervical Cancer Test (Screening) Population & Forecast
    • 14.1.1 Sweden Pap Smear Test Population
    • 14.1.2 Sweden HPV DNA Test Population
  • 14.2 Sweden Cervical Cancer Mortality
  • 14.3 Cervical Cancer Test (Screening) Market & Forecast
    • 14.3.1 Sweden Pap Smear Test Market
    • 14.3.2 Sweden HPV DNA Test Market

15. Switzerland - Cervical Cancer Test Analysis

  • 15.1 Switzerland Cervical Cancer Test (Screening) Population & Forecast
    • 15.1.1 Switzerland Pap Smear Test Population
    • 15.1.2 Switzerland HPV DNA Test Population
  • 15.2 Switzerland Cervical Cancer Mortality
  • 15.3 Switzerland Cervical Cancer Test (Screening) Market & Forecast
    • 15.3.1 Switzerland Pap Smear Test Market
    • 15.3.2 Switzerland HPV DNA Test Market

16. Norway - Cervical Cancer Test Analysis

  • 16.1 Norway Cervical Cancer Test (Screening) Population & Forecast
    • 16.1.1 Norway Pap Smear Test Population
    • 16.1.2 Norway HPV DNA Test Population
  • 16.2 Norway Cervical Cancer Mortality
  • 16.3 Norway Cervical Cancer Test (Screening) Market & Forecast
    • 16.3.1 Norway Pap Smear Test Market & Forecast
    • 16.3.2 Norway HPV DNA Test Market

17. Netherlands - Cervical Cancer Test Analysis

  • 17.1 Netherlands Cervical Cancer Test (Screening) Population & Forecast
    • 17.1.1 Netherlands Pap Smear Test Population
    • 17.1.2 Netherlands HPV DNA Test Population
  • 17.2 Netherlands Cervical Cancer Mortality
  • 17.3 Netherlands Cervical Cancer Test (Screening) Market & Forecast
    • 17.3.1 Netherlands Pap Smear Test Market
    • 17.3.2 Netherlands HPV DNA Test Market

18. United States - Cervical Cancer Test Analysis

  • 18.1 United States Cervical Cancer Test (Screening) Population & Forecast
    • 18.1.1 United States Pap smear Test Population
    • 18.1.2 United States HPV DNA Test Population
  • 18.2 United States Cervical Cancer Mortality
  • 18.3 United States Cervical Cancer Test (Screening) Market
    • 18.3.1 United States Pap Smear Test Market
    • 18.3.2 United States HPV DNA Test Market

19. Canada - Cervical Cancer Test Analysis

  • 19.1 Canada Cervical Cancer Test (Screening) Population & Forecast
    • 19.1.1 Canada Pap smear Test Population
    • 19.1.2 Canada HPV DNA Test Population
  • 19.2 Canada Cervical Cancer Mortality
  • 19.3 Canada Cervical Cancer Test (Screening) Market & Forecast
    • 19.3.1 Canada Pap Smear Test Market
    • 19.3.2 Canada HPV DNA Test Market

20. Japan - Cervical Cancer Test Analysis

  • 20.1 Japan Cervical Cancer Test (Screening) Population & Forecast
    • 20.1.1 Japan Pap smear Test Population
    • 20.1.2 Japan HPV DNA Test Population
  • 20.2 Japan Cervical Cancer Mortality
  • 20.3 Japan Cervical Cancer Test (Screening) Market & Forecast
    • 20.3.1 Japan Pap Smear Test Market
    • 20.3.2 Japan HPV DNA Test Market

21. South Korea - Cervical Cancer Tests Analysis

  • 21.1 South Korea - Cervical Cancer Test (Screening) Population & Forecast
    • 21.1.1 South Korea Pap Smear Test Population
    • 21.1.2 Korea HPV DNA Test Population
  • 21.2 Korea Cervical Cancer Mortality
  • 21.3 Korea Cervical Cancer Test (Screening) Market & Forecast
    • 21.3.1 Korea Pap Smear Test Market
    • 21.3.2 Korea HPV DNA Test Market

22. Singapore - Cervical Cancer Tests Analysis

  • 22.1 Singapore - Cervical Cancer Test (Screening) Population & Forecast
    • 22.1.1 Singapore Pap Smear Test Population
    • 22.1.2 Singapore HPV DNA Test Population
  • 22.2 Singapore Cervical Cancer Test (Screening) Market & Forecast
    • 22.2.1 Singapore Pap Smear Test Market
    • 22.2.2 Singapore HPV DNA Test Market

23. Malaysia - Cervical Cancer Test Analysis

  • 23.1 Malaysia - Cervical Cancer Test (Screening) Population & Forecast
    • 23.1.1 Malaysia Pap Smear Test Population
    • 23.1.2 Malaysia HPV DNA Test Population
  • 23.2 Malaysia Cervical Cancer Test (Screening) Market & Forecast
    • 23.2.1 Malaysia Pap Smear Test Market
    • 23.2.2 Malaysia HPV DNA Test Market

24. India - Cervical Cancer Test Analysis

  • 24.1 India - Cervical Cancer Test (Screening) Population & Forecast
    • 24.1.1 India Pap Smear Test Population
    • 24.1.2 India HPV DNA Test Population
    • 24.1.3 India VIA Test Population
  • 24.2 India Cervical Cancer Test (Screening) Market & Forecast
    • 24.2.1 India Pap Smear Test Market
    • 24.2.2 India HPV DNA Test Market
    • 24.2.3 India VIA Test Market

25. China - Cervical Cancer Test Analysis

  • 25.1 China - Cervical Cancer Test (Screening) Population & Forecast
    • 25.1.1 China Pap Smear Test Population
    • 25.1.2 China HPV DNA Test Population
    • 25.1.3 China VIA Test Population
  • 25.2 China - Cervical Cancer Test (Screening) Market & Forecast
    • 25.2.1 China Pap Smear Test Market
    • 25.2.2 China HPV DNA Test Market
    • 25.2.3 China VIA Test Market

26. Thailand - Cervical Cancer Test Analysis

  • 26.1 Thailand - Cervical Cancer Test (Screening) Population & Forecast
    • 26.1.1 Thailand Pap Smear Test Population
    • 26.1.2 Thailand VIA Test Population
  • 26.2 Thailand Cervical Cancer Test (Screening) Market & Forecast
    • 26.2.1 Thailand Pap Smear Test Market
    • 26.2.2 Thailand VIA Test Market

27. Indonesia - Cervical Cancer Test Analysis

  • 27.1 Indonesia Cervical Cancer Test (Screening) Population & Forecast
    • 27.1.1 Indonesia Pap Smear Test Population
    • 27.1.2 Indonesia HPV DNA Test Population
    • 27.1.3 Indonesia VIA Test Population
    • 27.1.4 Indonesia Pap Smear & VIA Test Population
  • 27.2 Indonesia Cervical Cancer Test (Screening) Market & Forecast
    • 27.2.1 Indonesia Pap Smear Test Market
    • 27.2.2 Indonesia HPV DNA Test Market
    • 27.2.3 Indonesia VIA Test Market
    • 27.2.4 Indonesia Pap smear & VIA Test Market

28. Rest of World - Cervical Cancer Test Analysis

  • 28.1 Rest of World Cervical Cancer Test (Screening) Population & Forecast
    • 28.1.1 Rest of World Pap smear Test Population
    • 28.1.2 Rest of World HPV DNA Test Population
  • 28.2 Rest of World Cervical Cancer Test (Screening) Market & Forecast
    • 28.2.1 Rest of World Pap Smear Test Market
    • 28.2.2 Rest of World HPV DNA Test Market

29. Growth Drivers

  • 29.1 Introduction of Low Cost VIA Test
    • 29.1.1 Countries Offering VIA Test via National Programs
    • 29.1.2 Countries Offering VIA Test via Pilot Programs
  • 29.2 Worldwide High Prevalence of HPV Infected Patients
  • 29.3 Rising Number of Incidence of Cervical Cancer in United Kingdom
  • 29.4 Worldwide Rising Incidence of Teenage Sexual Cases

30. Challenges

  • 30.1 Lack of Appropriate Healthcare Infrastructure
  • 30.2 Introduction of HPV Vaccination Programs Worldwide

List of Figures:

  • Figure 2-1: Global - Cervical Cancer Test Population (Million), 2013 - 2019
  • Figure 2-2: Global - Forecast for Cervical Cancer Test Population (Million), 2020 - 2026
  • Figure 2-3: Asia - Cervical Cancer Test Population (Million), 2013- 2019
  • Figure 2-4: Asia - Forecast for Cervical Cancer Test Population (Million), 2020 - 2026
  • Figure 2-5: Europe - Cervical Cancer Test Population (Million), 2013 - 2019
  • Figure 2-6: Europe - Forecast for Cervical Cancer Test Population (Million), 2020 - 2026
  • Figure 2-7: North America - Cervical Cancer Test Population (Million), 2013 - 2019
  • Figure 2-8: North America - Forecast for Cervical Cancer Test Population (Million), 2020 - 2026
  • Figure 3-1: Global - Cervical Cancer Test Market (Million US$), 2014 - 2019
  • Figure 3-2: Global - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 3-3: Global - Cervical Cancer Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 3-4: Global - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 3-5: Global - Cervical Cancer HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 3-6: Global - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 4-1: Asia - Cervical Cancer Test Market (Million US$), 2014 - 2019
  • Figure 4-2: Asia - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 4-3: Europe - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 4-4: Europe - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 4-5: North America - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 4-6: North America - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 5-1: Global - Cervical Cancer Test (Screening) Population Share (Percent) by Region,
  • Figure 5-2: Global - Forecast for Cervical Cancer Test (Screening) Population Share (Percent) by Region, 2020 - 2026
  • Figure 6-1: Global - Cervical Cancer Market Share (Percent) By Region, 2014 - 2019
  • Figure 6-2: Global - Forecast for Cervical Cancer Market Share (Percent) By Region, 2020 - 2026
  • Figure 7-1: United Kingdom - Cervical Cancer Test Population (Thousand), 2014 - 2019
  • Figure 7-2: United Kingdom - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 7-3: United Kingdom - Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2019
  • Figure 7-4: United Kingdom - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 7-5: United Kingdom - Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2019
  • Figure 7-6: United Kingdom - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 7-7: United Kingdom - Cervical Cancer Deaths (Number), 2014 - 2019
  • Figure 7-8: United Kingdom - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 7-9: United Kingdom - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 7-10: United Kingdom - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 7-11: United Kingdom - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 7-12: United Kingdom - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 7-13: United Kingdom - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 8-1: France - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 8-2: France - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 8-3: France - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 8-4: France - Forecast for Cervical Cancer Pap Smear Test Population (Thousand),
  • Figure 8-5: France - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 8-6: France - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 8-7: France - Cervical Cancer Mortality (Number), 2013 - 2020
  • Figure 8-8: France - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 8-9: France - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 8-10: France - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 8-11: France - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 8-12: France - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 8-13: France - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 9-1: Germany - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 9-2: Germany - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 9-3: Germany - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 9-4: Germany - Forecast for Cervical Cancer Pap Smear Test Population (Thousand),
  • Figure 9-5: Germany - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 9-6: Germany - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 9-7: Germany - Cervical Cancer Mortality (Number), 2011 - 2017
  • Figure 9-8: Germany - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 9-9: Germany - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 9-10: Germany - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 9-11: Germany - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 9-12: Germany - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 9-13: Germany - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 10-1: Italy - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 10-2: Italy - Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 10-3: Italy - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 10-4: Italy - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 10-5: Italy - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 10-6: Italy - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 10-7: Italy - Cervical Cancer Mortality (Number), 2013 - 2020
  • Figure 10-8: Italy - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 10-9: Italy - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 10-10: Italy - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 10-11: Italy - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 10-12: Italy - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 10-13: Italy - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 11-1: Spain - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 11-2: Spain - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 11-3: Spain - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 11-4: Spain - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 11-5: Spain - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 11-6: Spain - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 -2026
  • Figure 11-7: Spain - Cervical Cancer Mortality (Number), 2013 - 2020
  • Figure 11-8: Spain - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 11-9: Spain - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 11-10: Spain - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 11-11: Spain - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 11-12: Spain - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 11-13: Spain - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 12-1: Sweden - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 12-2: Sweden - Forecast for Cervical Cancer Pap smear Test Population (Thousand),
  • Figure 12-3: Sweden - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 12-4: Sweden - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 12-5: Sweden - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 12-6: Sweden - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 12-7: Sweden - Cervical Cancer Mortality (Number), 2013 - 2019
  • Figure 12-8: Sweden - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 12-9: Sweden - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 12-10: Sweden - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 12-11: Sweden - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 12-12: Sweden - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 12-13: Sweden - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 13-1: Switzerland - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 13-2: Switzerland - Forecast for Cervical Cancer Test Population (Thousand), 2020-2026
  • Figure 13-3: Switzerland - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 13-4: Switzerland - Forecast for Cervical Cancer Pap Smear Test Population (Thousand),
  • Figure 13-5: Switzerland - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 13-6: Switzerland - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 13-7: Switzerland - Cervical Cancer Mortality (Number), 2013 - 2020
  • Figure 13-8: Switzerland - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 13-9: Switzerland - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 13-10: Switzerland - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 13-11: Switzerland - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 13-12: Switzerland - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 13-13: Switzerland - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 14-1: Norway - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 14-2: Norway - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 14-3: Norway - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 14-4: Norway - Forecast for Cervical Cancer Pap Smear Test Population (Thousand),
  • Figure 14-5: Norway - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 14-6: Norway - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 14-7: Norway - Cervical Cancer Mortality (Number), 2013 - 2019
  • Figure 14-8: Norway - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 14-9: Norway - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 14-10: Norway - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 14-11: Norway - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 14-12: Norway - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 14-13: Norway - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 15-1: Netherlands - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 15-2: Netherlands - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 15-3: Netherlands - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 15-4: Netherlands - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020- 2026
  • Figure 15-5: Netherlands - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 15-6: Netherlands - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 15-7: Netherlands - Cervical Cancer Mortality (Number), 2013 - 2020
  • Figure 15-8: Netherlands - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 15-9: Netherlands - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 15-10: Netherlands - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 15-11: Netherlands - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 15-12: Netherlands - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 15-13: Netherlands - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 16-1: United States - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 16-2: United States - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 16-3: United States - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 16-4: United States - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 16-5: United States - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 16-6: United States - Forecast for Cervical Cancer HPV DNA Test Population (Thousand),
  • Figure 16-7: United States - Cervical Cancer Mortality (Number), 2013 - 2019
  • Figure 16-8: United States - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 16-9: United States - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 16-10: United States - Pap smear Test Market (Million US$), 2013 - 2019
  • Figure 16-11: United States - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 16-12: United States - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 16-13: United States - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 17-1: Canada - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 17-2: Canada - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 17-3: Canada - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 17-4: Canada - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 17-5: Canada - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 17-6: Canada - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 17-7: Canada - Cervical Cancer Mortality (Number), 2013 - 2019
  • Figure 17-8: Canada - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 17-9: Canada - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 17-10: Canada - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 17-11: Canada - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 17-12: Canada - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 17-13: Canada - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 18-1: Japan - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 18-2: Japan - Forecast for Cervical Cancer Test Population (Thousand), 2020- 2026
  • Figure 18-3: Japan - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 18-4: Japan - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 18-5: Japan - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 18-6: Japan - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 18-7: apan - Cervical Cancer Mortality (Number), 2013 - 2020
  • Figure 18-8: Japan - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 18-9: Japan - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 18-10: Japan - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 18-11: Japan - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 18-12: Japan - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 18-13: Japan - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 19-1: Korea - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 19-2: Korea - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 19-3: Korea - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 19-4: Korea - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 19-5: Korea - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 19-6: Korea - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 19-7: Korea - Cervical Cancer Mortality (Number), 2013 - 2020
  • Figure 19-8: Korea - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 19-9: orea - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 19-10: Korea - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 19-11: Korea - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 19-12: Korea - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 19-13: Korea - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 20-1: Singapore - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 20-2: Singapore - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 20-3: Singapore - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 20-4: Singapore - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 20-5: Singapore - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 20-6: Singapore - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 20-7: Singapore - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 20-8: Singapore - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 20-9: Singapore - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 20-10: Singapore - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 20-11: Singapore - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 20-12: Singapore - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 21-1: Malaysia - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 21-2: Malaysia - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 21-3: Malaysia - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 21-4: Malaysia - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 21-5: Malaysia - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 21-6: Malaysia - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 21-7: Malaysia - Cervical Cancer Test Market (Million US$), 2013- 2019
  • Figure 21-8: Malaysia - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 21-9: Malaysia - Pap smear Test Market (Million US$), 2013 - 2019
  • Figure 21-10: Malaysia - Forecast for Pap smear Test Market (Million US$), 2020 - 2026
  • Figure 21-11: Malaysia - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 21-12: Malaysia - Forecast for HPV DNA Test Market (Million US$), 2020- 2026
  • Figure 22-1: India - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 22-2: India - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 22-3: India - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 22-4: India - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 22-5: India - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 22-6: India - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 22-7: India - Cervical Cancer VIA Test Population (Thousand), 2013 - 2019
  • Figure 22-8: India - Forecast for Cervical Cancer VIA Test Population (Thousand), 2020 - 2026
  • Figure 22-9: India - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 22-10: India - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 22-11: India - Pap smear Test Market (Million US$), 2013 - 2019
  • Figure 22-12: India - Forecast for Pap smear Test Market (Million US$), 2020 - 2026
  • Figure 22-13: India - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 22-14: India - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 22-15: India - VIA Test Market (Million US$), 2013 - 2019
  • Figure 22-16: India - Forecast for VIA Test Market (Million US$), 2020 - 2026
  • Figure 23-1: China - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 23-2: China - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 23-3: China - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 23-4: China - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 23-5: China - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 23-6: China - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 23-7: China - Cervical Cancer VIA Test Population (Thousand), 2013 - 2019
  • Figure 23-8: China - Forecast for Cervical Cancer VIA Test Population (Thousand), 2020 - 2026
  • Figure 23-9: China - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 23-10: China - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 23-11: China - Pap smear Test Market (Million US$), 2013 - 2019
  • Figure 23-12: China - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 23-13: China - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 23-14: China - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 23-15: China - VIA Test Market (Million US$), 2013 - 2019
  • Figure 23-16: China - Forecast for VIA Test Market (Million US$), 2020 - 2026
  • Figure 24-1: Thailand - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 24-2: Thailand - Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 24-3: Thailand - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 24-4: Thailand - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 24-5: Thailand - Cervical Cancer VIA Test Population (Thousand), 2013 - 2019
  • Figure 24-6: Thailand - Forecast for Cervical Cancer VIA Test Population (Thousand), 2020 - 2026
  • Figure 24-7: Thailand - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 24-8: Thailand - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 24-9: Thailand - Pap smear Test Market (Million US$), 2013 - 2019
  • Figure 24-10: Thailand - Forecast for Pap Smear Test Market (Million US$), 2020 - 2029
  • Figure 24-11: Thailand - VIA Test Market (Million US$), 2013 - 2019
  • Figure 24-12: Thailand - Forecast for VIA Test Market (Million US$), 2020 - 2026
  • Figure 25-1: Indonesia - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 25-2: Indonesia - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 25-3: Indonesia - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 25-4: Indonesia - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 25-5: Indonesia - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 25-6: Indonesia - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 - 2026
  • Figure 25-7: Indonesia - Cervical Cancer VIA Test Population (Thousand), 2013 - 2019
  • Figure 25-8: Indonesia - Forecast for Cervical Cancer VIA Test Population (Thousand), 2020 - 2026
  • Figure 25-9: Indonesia - Cervical Cancer Both (Pap smear & VIA) Test Population (Thousand), 2013 - 2019
  • Figure 25-10: Indonesia - Forecast for Cervical Cancer Both (Pap smear & VIA) Test Population (Thousand), 2020 - 2026
  • Figure 25-11: Indonesia - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 25-12: Indonesia - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 25-13: Indonesia - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 25-14: Indonesia - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 25-15: Indonesia - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 25-16: Indonesia - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026
  • Figure 25-17: Indonesia - VIA Test Market (Million US$), 2013 - 2019
  • Figure 25-18: Indonesia - Forecast for VIA Test Market (Million US$), 2020 - 2026
  • Figure 25-19: Indonesia - Both (Pap smear & VIA) Test Market (Million US$), 2013 - 2019
  • Figure 25-20: Indonesia - Forecast for Both (Pap smear & VIA) Test Market (Million US$), 2020 - 2026
  • Figure 26-1: Rest of World - Cervical Cancer Test Population (Thousand), 2013 - 2019
  • Figure 26-2: Rest of World - Forecast for Cervical Cancer Test Population (Thousand), 2020 - 2026
  • Figure 26-3: Rest of World - Cervical Cancer Pap Smear Test Population (Thousand), 2013 - 2019
  • Figure 26-4: Rest of World - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 - 2026
  • Figure 26-5: Rest of World - Cervical Cancer HPV DNA Test Population (Thousand), 2013 - 2019
  • Figure 26-6: Rest of World - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020- 2026
  • Figure 26-7: Rest of World - Cervical Cancer Test Market (Million US$), 2013 - 2019
  • Figure 26-8: Rest of World - Forecast for Cervical Cancer Test Market (Million US$), 2020 - 2026
  • Figure 26-9: Rest of World - Pap Smear Test Market (Million US$), 2013 - 2019
  • Figure 26-10: Rest of World - Forecast for Pap Smear Test Market (Million US$), 2020 - 2026
  • Figure 26-11: Rest of World - HPV DNA Test Market (Million US$), 2013 - 2019
  • Figure 26-12: Rest of World - Forecast for HPV DNA Test Market (Million US$), 2020 - 2026

List of Tables:

  • Table 5-1: Global -Cervical Cancer Test Population Share (Percent) By Country, 2014 - 2019
  • Table 5-2: Global - Forecast for Cervical Cancer Test Population Share (Percent) by Country,
  • Table 6-1: Global - Cervical Cancer Test Market Share (Percent) by Country, 2014 - 2019
  • Table 6-2: Global - Forecast for Cervical Cancer Test Market Share (Percent) by Country, 2020 - 2026
  • Table 6-3: Global - Pap Smear Test Market Share (Percent), 2014 - 2019
  • Table 6-4: Global - Forecast for Pap Smear Test Market Share (Percent), 2020 - 2026
  • Table 6-5: Global - HPV DNA Test Market Share (Percent), 2014 - 2019
  • Table 6-6: Global - Forecast for HPV DNA Test Market Share (Percent), 2020 - 2026
  • Table 6-7: Global - VIA Test Market Share (Percent), 2013 - 2019
  • Table 6-8: Global - Forecast for VIA Test Market Share (Percent), 2020 - 2026
  • Table 26-1: Worldwide - List of Countries which offer VIA Test via National Programs, 2015
  • Table 26-2: Worldwide - List of Countries which offer VIA Test via Pilot Programs, 2015
  • Table 26-3: Worldwide - Prevalence of HPV 16/18 in Women with Normal Cervical Cytology (Percent), 2014 - 2015
  • Table 26-4: United Kingdom - Number of Incidence Observed and Projected and their respective Age Standardized Rate, 2010 - 2025
  • Table 26-5: Worldwide - Prevalence (Percent) of Young Women (15-44 Years) who Have Sex before the Age of 15 Years, 1994 - 2006